Predictors and long-term outcome of super-responders to cardiac resynchronization therapy

Clinical Cardiology

Volumn 40, Issue 5, 2017, Pages 292-299

  Ghani, Abdul ^a   Delnoy, Peter Paul H M ^a   Adiyaman, Ahmet ^a   Ottervanger, Jan Paul ^a   Ramdat Misier, Anand R ^a   Smit, Jaap Jan J ^a   Elvan, Arif ^a  

^a Department of Obstetrics and Gynaecology   (Netherlands)

Author keywords

cardiac resynchronization therapy; long term prognosis and predictors; super response

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; QRS INTERVAL; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CONVALESCENCE; DEVICES; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEX FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 85015243093     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22658     Document Type: Article

References (22)

1. Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization–Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549.
2. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
3. Linde C, Gold MR, Abraham WT, et al; Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction Study Group. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Eur Heart J. 2013;34:2592–2599.
4. Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53:483–490.
5. Solomon SD, Foster E, Bourgoun M, et al; MADIT-CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy. Circulation. 2010;122:985–992.
6. Hsu JC, Solomon SD, Bourgoun M, et al; MADIT-CRT Executive Committee. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy) study. J Am Coll Cardiol. 2012;59:2366–2373.
7. Rickard J, Cheng A, Spragg D, et al. Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of “nonresponders.” Heart Rhythm. 2014;11:412–416.
8. Zecchin M, Proclemer A, Magnani S, et al. Long-term outcome of ‘super-responder’ patients to cardiac resynchronization therapy. Europace. 2014;16:363–371.
9. Frigerio M, Lunati M, Pasqualucci D, et al. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience. Int J Cardiol. 2014;172:64–71.
10. Epstein AE, Dimarco JP, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary [published correction appears in Heart Rhythm. 2009;6:e1]. Heart Rhythm. 2008;5:934–955.
11. Van Boven N, Bogaard K, Ruiter J, et al. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks. J Cardiovasc Electrophysiol. 2013;24:316–322.
12. Manne M, Rickard J, Varma N, et al. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival. Pacing Clin Electrophysiol. 2013;36:970–977.
13. Lang RM, Bierig M, Devereux RB, et al; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.
14. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457–464.
15. Ellenbogen KA, Huizar JF. Foreseeing super-response to cardiac resynchronization therapy: a perspective of clinicians. J Am Coll Cardiol. 2012;59:2374–2377.
16. Serdoz LV, Daleffe E, Merlo M, et al. Predictors of restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. Am J Cardiol. 2011;108:75–80.
17. Killu AM, Grupper A, Friedman PA, et al. Predictors and outcomes of super-responders to cardiac resynchronization therapy. J Cardiac Fail. 2014;20:379–386.
18. Rapacciuolo A, Maffè S, Palmisano P, et al. Prognostic role of right ventricular function in patients with heart failure undergoing cardiac resynchronization therapy. Clin Cardiol. 2016. doi:10.1002/clc.22574.
19. Barsheshet A, Wang PJ, Moss AJ, et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization therapy). J Am Coll Cardiol. 2011;57:2416–2423.
20. Gold MR, Linde C, Abraham WT, et al. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm. 2011;8:679–684.
21. van der Heijden AC, Höke U, Thijssen J, et al. Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment. Eur J Heart Fail. 2014;16:1104–1111.
22. Chatterjee NA, Roka A, Lubitz SA, et al. Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy–induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J. 2015;36:2780–2789.